Nakae covers the Healthcare sector, focusing on stocks such as Allurion Technologies, Silence Therapeutics, and SAB Biotherapeutics. ;'> The word on The Street in general, suggests a Strong Buy ...

PatientRightsAdvocate.org (PRA) is urging Nevada Governor Joe Lombardo to sign A.B. 343, major legislation to deliver hospital price transparency to Nevadans that was passed out of the Nevada ...

Acadia Pharmaceuticals Inc. today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 4:00 p.m. Eastern Time.

Investors await the Federal Reserve's minutes from its latest policy meeting, at which the central bank held rates steady and warned of rising economic risks. But Nvidia is poised to dominate the ...

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in ...

Allurion Technologies said patients treated with its weight-loss program in a clinical study maintained higher muscle mass and had a bigger decrease in fat percentage. The developer of obesity ...

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

Allurion Technologies, Inc. (ALUR) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of a loss of $1.53 per share. This compares to earnings of $2.75 per ...

Allurion Technologies Inc. (ALUR) reported a notable decline in revenue for Q1 2025, with figures decreasing to $5.6 million from $9.4 million in the same period last year. Despite the revenue ...